NCT04815824

Brief Summary

Endurance exercise is often recommended to improve cardiometabolic health and maintain bone health throughout life and to prevent osteoporotic fracture. However, there is evidence to suggest that bone does not always adapt in the way that is expected, and that endurance exercise may lead to bone loss under certain conditions. Disruptions in calcium homeostasis during exercise may explain this observation, and preliminary data suggests that the mode of exercise (i.e., cycling versus treadmill) may result in different magnitudes of change in bone biomarkers. The purpose of this study is to determine if mode of exercise results in a differential bone biomarker response to an acute exercise bout in older Veterans. Blood samples will be collected before, during, and after 2 acute exercise bouts: 1) brisk treadmill walking; and 2) vigorous stationary cycling. Bouts will be matched for relative intensity and duration. This data will be used to develop future exercise interventions in older Veterans aimed at preserving both cardiometabolic and bone health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

October 8, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

July 20, 2025

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

2.7 years

First QC Date

March 22, 2021

Results QC Date

June 5, 2025

Last Update Submit

July 18, 2025

Conditions

Keywords

exercisebone resorptioncalcium

Outcome Measures

Primary Outcomes (1)

  • C-telopeptide of Type I Collagen (CTX) Change

    CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.

    Before to up to 48 hours after acute exercise bout

Secondary Outcomes (1)

  • Procollagen of Type I N-terminal Propeptide (P1NP) Change

    Before to up to 48 hours after acute exercise bout

Study Arms (2)

Stationary Cycling

EXPERIMENTAL

All participants will complete one, 60-minute bout of stationary cycling

Behavioral: Exercise Mode

Treadmill Walking

EXPERIMENTAL

All participants will complete one, 60-minute bout of treadmill walking

Behavioral: Exercise Mode

Interventions

Exercise ModeBEHAVIORAL

Stationary cycling or treadmill walking

Stationary CyclingTreadmill Walking

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy older (60+ y) Veteran women and men will be eligible to participate
  • All volunteers must be accustomed to performing 60 minutes of vigorous cycling and treadmill exercise

You may not qualify if:

  • impaired renal function, defined as an eGRF of \<60 mL/min/1.73m2;(Florkowski and Chew-Harris 2011)
  • hepatobiliary disease, defined as liver function tests (AST, ALT) \>1.5 times the upper limit of normal
  • thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \<0.5 or \>5.0 mU/L
  • serum Ca \<8.5 or \>10.3 mg/dL; 5) serum 25(OH)D \<20 ng/mL
  • uncontrolled hypertension, defined as resting systolic blood pressure (BP) \>150 mmHg or diastolic BP \>90 mmHg
  • history of type 1 or type 2 diabetes
  • cardiovascular disease; defined as subjective or objective indicators of ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test (GXT)
  • volunteers who have a positive GXT can be re-considered after follow-up evaluation, which must include diagnostic testing (e.g., stress echocardiogram or thallium stress test) with interpretation by a cardiologist
  • anemia, defined as a serum hemoglobin \<12.1 g/dL for women and \<14.3 g/dL for men
  • fracture in the past 6 months
  • current diagnosis or symptoms of COVID-19
  • In the event of abnormal BP, live function, TSH, 25(OH)D, or hemoglobin values, volunteers can be reassessed, including after appropriate follow-up evaluation and treatment by a primary care provider
  • Those who have experienced symptoms of COVID-19 or have been formally diagnosed will be allowed to participate once symptoms have resolved and they are approved to return to exercise by their primary care provider

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, 80045-7211, United States

Location

MeSH Terms

Conditions

OsteoporosisMotor ActivityBone Resorption

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Results Point of Contact

Title
Dr. Sarah Wherry
Organization
VA Eastern Colorado Health Care System

Study Officials

  • Sarah J Wherry, PhD

    Rocky Mountain Regional VA Medical Center, Aurora, CO

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Crossover design comparing mode of endurance exercise (cycling versus treadmill).
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2021

First Posted

March 25, 2021

Study Start

October 8, 2021

Primary Completion

June 30, 2024

Study Completion

September 30, 2024

Last Updated

July 20, 2025

Results First Posted

July 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations